Toronto · Seed–Series B · 12 people tracked
Find your way into Genesys Capital
1,916 people in our graph share verified history with the Genesys Capital team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Genesys Capital focuses on the high-growth sectors of biotechnology, pharmaceuticals, and medical technology, investing across the lifecycle from seed to commercial impact. Leveraging over 25 years of experience and long-standing partnerships with leading North American research institutes and universities, the firm gains early access to top-tier scientific discoveries and differentiated deal flow. Genesys often co-creates and builds companies alongside scientific founders and entrepreneurs, acting as a thought partner to shape the future of healthcare. Its strategy aims to deliver strong, repeatable returns to investors while advancing medicine that addresses pressing unmet medical needs.
Source: firm website, verified Aug 3, 2026.
Team · 12 people
from the firm's website & curated & public directoriesWhat they invest in
from 8 of 18 portfolio companiesBiotech ×6Medical Devices ×6Deep Tech ×4Healthtech ×4Hardware ×2AI & Machine Learning ×1Digital Health ×1
HQs:Canada×4United States×1
Investments · 18 tracked
founders shown can be your intro pathBy year:2024 · 12022 · 12 dated
Profound Medical develops real-time MRI-guided thermal ultrasound systems for incision-free ablation of abnormal or cancerous tissue.
BiotechDeep TechHealthtechMedical DevicesMississauga
Arun Menawat(CEO and Chairman of the Board)inRashed Dewan(Executive Officer)inMathieu Burtnyk(Chief Operating Officer)inTom Tamberrino(Chief Commercial Officer)
BoardJean-Francois Pariseau(Director)Damian Lamb(Director)
Co-investorsCTI Life Sciences Fund L.P.FACIT (Fight Against Cancer Innovation Trust)
Adapsyn Bioscience is a biotech company focused on discovering and developing microbial natural product small molecules for therapeutic applications by leveraging genomic and chemical biology approaches.
AI & Machine LearningBiotechDeep TechHamilton, CA
Nathan Magarvey(Founder)
Co-investorsPfizer Venture Investments
Antegrade Medical is a Quebec City-based medical device startup developing single-use procedural tools enabling an antegrade approach for structural interventional cardiology procedures.
Cryostasis develops the Woolii SU (Subzero Unfrozen) platform, a preservation system that stores cell therapy products at subzero temperatures without freezing or cryoprotectants.
BiotechDeep TechHardwareHealthtechMedical Devices
EBT Medical develops neuromodulation technologies targeting the Saphenous nerve to treat pelvic health disorders, particularly overactive bladder.
BiotechMedical Devices
Paul Yoo(Co-founder, President & Chief Scientific Officer)inSasha John(Co-founder and Chief Innovation Officer)inKeith R Carlton(Chief Executive Officer)in
Co-investorsSV Health InvestorsToronto Innovation Acceleration Partners
Enspire DBS is conducting a clinical trial evaluating Deep Brain Stimulation combined with physical therapy (DBS + Rehab) to assess safety and whether it can improve arm function in stroke patients with lasting impairment.
HealthtechMedical Devices
Co-investorsJobsOhio Ventures
Feldan is a clinical-stage biotech company developing intracellular delivery technologies for therapeutic treatment of diseases.
BiotechDeep TechMedical Devices
François-Thomas Michaud(Board Member & Chief Executive Officer)in
Co-investorsLinearis VenturesFonds de solidarité FTQZynext Ventures
Flosonics Medical makes FloPatch, a wireless wearable Doppler ultrasound device that assesses a patient's carotid arterial pulse in real time to give clinicians hemodynamic data for fluid resuscitation decisions.
Digital HealthHardwareMedical Devices
Joe Eibl(Founder)in
Co-investorsAmplify CapitalArboretum VenturesiGan PartnersNew Leaf Venture PartnersRBCx
Fusion Pharma develops targeted alpha therapeutics that link alpha-emitting medical isotopes to molecules targeting biomarkers on cancer cell surfaces to selectively kill tumor cells.
BiotechHealthtech
Co-investorsFACIT (Fight Against Cancer Innovation Trust)HealthCapLumira VenturesSeroba Life SciencesVenture OntarioYsios Capital+2 more
Scalable, high throughput DNA sequencing platforms.
Co-investorsARCH Venture PartnersArtis VenturesHemisphere Ventures LLCHeran PartnersSPRINGROCK VENTURESVenrock
Portfolio company acquired by Novo Nordisk for $1.1B USD.
Co-investorsAmorChemJDRF T1D FundNew Enterprise Associates (NEA)Tarnagulla VenturesadMare BioInnovationsAmgen Ventures+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Adapsyn Bioscience IncFunction NeuromodulationFusionGiiantGiiant Pharma IncQuestat IncVeralox Therapeutics Inc
Exits · 4
1 IPOs · 3 acquisitions · showing 3Profound MedicalNASDAQ: PROFFusionacq. by AlumniInversagoacq. by Novo Nordisk
Portfolio news
latest coverage across their companiesProfound Medical · stocktitan.net · Sep 3, 2026
Frequently asked questions
- How many investments has Genesys Capital made?
- Genesys Capital has 18 tracked investments, 4 of which have exited.
- What stage does Genesys Capital invest at?
- Genesys Capital invests at the Seed, Series A, Series B stages.
- What is Genesys Capital's typical check size?
- Genesys Capital typically writes checks of $730K – $3.6M.
- What sectors does Genesys Capital focus on?
- Genesys Capital focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Genesys Capital located?
- Genesys Capital is headquartered in Toronto, CA.
- Who does Genesys Capital co-invest with?
- Genesys Capital most often shares deals with Amplify Capital, Arboretum Ventures, JobsOhio Ventures, among 14 tracked co-investors.
Images
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
HealthQuad is a healthcare-focused investment firm that partners with entrepreneurs building category-defining healthcare businesses, leveraging its healthcare network and clinical/operating expertise.
















































.jpeg)

